Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

COLL

COLLEGIUM PHARMACEUTICAL, INC

Pharmaceutical Preparations · SIC 2834CIK 1267565Held by 5 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$781.0M
Net Income FY2025
$63.0M
EPS (Basic, as reported)
$1.98
Net Margin FY2025
8.1%
ROE FY2025
20.8%
Total Equity
$302.0M
Shares Out
33M
Business description

COLLEGIUM PHARMACEUTICAL, INC — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2013–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 2 → 781 +94.1% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue228280297310277464567631781
Cost of revenue0(3)(166)(194)(130)(126)(254)(241)(254)(317)
Gross profit——115103180151209326377463
Research & development(15)(9)(9)(10)(10)(9)(4)00—
Selling, general & administrative(81)(93)(127)(116)(114)(119)(172)(159)(210)(285)
General & administrative——————————
Total operating expenses(96)(104)(135)(127)(124)(133)(176)(159)(207)(284)
Operating income(94)(75)(21)(24)561833167170180
Interest expense0—(20)(1)(29)(21)(63)(83)(74)(82)
Other income (expense), net01————————
Pre-tax income——(39)(23)28(3)(29)769993
Income tax expense———0(1)(75)(4)(28)(29)(30)
Net income(94)(75)(39)(23)2772(25)486963
EPS — basic($3.88)—($1.19)($0.68)$0.78$2.05($0.74)$1.43$2.14$1.98
EPS — diluted——($1.19)($0.68)$0.76$1.86($0.74)$1.29$1.86$1.73
Shares outstanding — basic (M)——3333343534343232
Shares outstanding — diluted (M)——3333354134424040

Showing the latest 10 of 13 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.